United States · FDA National Drug Code directory
Ondansetron HCL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80425-0074_4ceff209-9877-7129-e063-6294a90a6fdc
- Product NDC
- 80425-0074
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ondansetron HCL
- Labeler
- Advanced Rx of Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200916
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET, FILM COATED in 1 BOTTLE (80425-0074-1) · 80425-0074-1
- 15 TABLET, FILM COATED in 1 BOTTLE (80425-0074-2) · 80425-0074-2
- 20 TABLET, FILM COATED in 1 BOTTLE (80425-0074-3) · 80425-0074-3
- 30 TABLET, FILM COATED in 1 BOTTLE (80425-0074-4) · 80425-0074-4
- 60 TABLET, FILM COATED in 1 BOTTLE (80425-0074-5) · 80425-0074-5
- 9 TABLET, FILM COATED in 1 BOTTLE (80425-0074-6) · 80425-0074-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →